Consultant Epidemiologist
IQVIA
Dr. Shah is a Consultant Epidemiologist with the Epidemiology and Drug Safety Team at IQVIA. He is a clinical pharmacoepidemiologist by training, with more than seven years of experience conceptualizing, designing, and leading real-world studies. He has published over 26 peer-reviewed articles and delivered more than 20 conference presentations. Dr. Shah’s expertise lies in evaluating novel interventions using real world data and state-of-the-art biostatistical and missing data methods; generating real world evidence from such novel interventions; and, optimizing pharmacoepidemiology research methods to adapt to patients with cancer. Before joining IQVIA, Dr. Shah completed a T-32-funded postdoctoral fellowship in clinical pharmacoepidemiology. Prior to this training, he completed a postdoctoral fellowship in internal medicine and oncologic emergency medicine at the UT MD Anderson Cancer Center. Dr. Shah earned a Master of Science in Clinical Epidemiology (MSCE) from the Perelman School of Medicine at the University of Pennsylvania, and a medical doctorate from the University of Health Sciences.
